The pathogenesis of Alzheimer disease may involve an impaired IL-33/ST2 signaling, with the inhibition of β amyloid phagocytosis and clearance by microglia, which promotes chronic neuroinflammation and amyloid plaque deposition [112]. This evidence concerns the gene IL33 and Alzheimer disease.